Pancreatic Neoplasms: all 3,310 studies
Page 2 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Venous Resection in Patients Undergoing Pancreatic SurgeryNot yet recruitingNCT07621029
- Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT07619521Phase 1/2
- Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic NeoplasmsEnrolling by invitationNCT07619417Not applicable
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic CancerRecruitingNCT07619313Phase 1
- Immune Repertoire Decoding for Chronic Pancreatitis-to-Pancreatic Cancer Risk StratificationNot yet recruitingNCT07612566
- A Study of Magnetic Resonance Imaging of the Pancreas for Cancer ScreeningRecruitingNCT07612046
- 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic CancerNot yet recruitingNCT07608627Phase 1
- Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyNot yet recruitingNCT07608458Not applicable
- Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic PatientsRecruitingNCT07608055
- Clinical, Oncological and Metabolic Effects of Pancreatic Mass Loss After Partial, Near-total and Total Pancreatectomy in Patients With Preoperative Diabetes MellitusNot yet recruitingNCT07607912
- Comparison of a Short Modified Metal Stent Versus Plastic Stent as a Bridge to Surgery in Pancreatic Cancer With Malignant Biliary ObstructionNot yet recruitingNCT07606430Not applicable
- Pancreatic Cancer Screening Using the Enzeavour Assay in JapanRecruitingNCT07605819Not applicable
- The Canopy Cancer Collective Clinical Registry ProtocolNot yet recruitingNCT07605702
- Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic CancerRecruitingNCT07600268Phase 2
- Preliminary Trial of SNA014 for Pancreatic CancerRecruitingNCT07597772Early Phase 1
- ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)Not yet recruitingNCT07597252
- Statewide Unified Network for Remote Intervention of Strength and ExerciseNot yet recruitingNCT07596732Not applicable
- CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic CancerRecruitingNCT07595835Phase 1/2
- NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic CancerRecruitingNCT07595172Phase 1/2
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP DeletionRecruitingNCT07594626Phase 1/2
- To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDACRecruitingNCT07591571Not applicable
- Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer PatientsNot yet recruitingNCT07591480
- An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic CancerRecruitingNCT07589569Phase 2
- Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic CancerNot yet recruitingNCT07587827Phase 1
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 2
- A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.Not yet recruitingNCT07578337Phase 2
- Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNANot yet recruitingNCT07574957
- A 2-part Phase 1/2 Open-label Trial on ODM-212RecruitingNCT07563738Phase 1/2
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07562152Phase 3
- A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal DataRecruitingNCT07561814
- Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple ProcedureRecruitingNCT07560540Not applicable
- Multicentric Database for KRAS Mutant Pancreatic CancerRecruitingNCT07557849
- A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic CancerNot yet recruitingNCT07557394Phase 4
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid TumorsNot yet recruitingNCT07555600Not applicable
- Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET ImagingNot yet recruitingNCT07554742
- Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer PatientsNot yet recruitingNCT07553793Phase 1
- Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsRecruitingNCT07552467
- PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)RecruitingNCT07549958Phase 1
- Artidis Nanomechanical Signature Profiling of Pancreatic Cancer SpecimensRecruitingNCT07542041Not applicable
- Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory StudyRecruitingNCT07542002Phase 2
- Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic CancerRecruitingNCT07539155Phase 1/2
- Validation of the Odesa Criteria 2026 for Autoimmune PancreatitisRecruitingNCT07536841
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaRecruitingNCT07529808Phase 1/2
- Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic CancerRecruitingNCT07529626
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic CancerNot yet recruitingNCT07528430
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsRecruitingNCT07523529Phase 1/2
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07522073Phase 3
- Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07516392Not applicable
- Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing ScreeningRecruitingNCT07513116Not applicable
- Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver MetastasesRecruitingNCT07504471Phase 2
- Phase 1/2a Study of RP-001 in Participants With Advanced MalignanciesNot yet recruitingNCT07504263Phase 1/2
- SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical ConsentNot yet recruitingNCT07494994Not applicable
- To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.RecruitingNCT07493421Not applicable
- A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)RecruitingNCT07492680Phase 2
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07491445Phase 3
- Microplastics in Pancreas: Oncologic and Metabolic ImpactNot yet recruitingNCT07486128
- A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic CancerRecruitingNCT07481383Phase 1
- Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT07480928Phase 1/2
- Prehab for Pancreatic Cancer SurgeryRecruitingNCT07478185Not applicable
- PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)Not yet recruitingNCT07477418Phase 1/2
- Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic CancerNot yet recruitingNCT07470268Not applicable
- Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic CancerNot yet recruitingNCT07469956Phase 2
- A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationRecruitingNCT07458347Phase 1
- A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07450859Phase 2
- EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and MetastasesNot yet recruitingNCT07448376
- Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer PainRecruitingNCT07445386Not applicable
- ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic CancerRecruitingNCT07444541Phase 1/2
- AI-Powered Precision Decision-Making for Pancreatic DiseasesRecruitingNCT07439757
- Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerRecruitingNCT07436312Not applicable
- Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid TumorRecruitingNCT07433283Phase 1/2
- Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for CancerRecruitingNCT07429487Not applicable
- CAR-NK Cells (CL-NK-003) in Pancreatic CancerRecruitingNCT07425483Phase 1
- PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)Not yet recruitingNCT07422103Not applicable
- Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas UnitsNot yet recruitingNCT07418164
- IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic CancerNot yet recruitingNCT07415525Phase 2
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerRecruitingNCT07409272Phase 3
- Operative Risk After Pancreatic Surgery in Patients With End Stage Renal DiseaseEnrolling by invitationNCT07405099
- INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)RecruitingNCT07403630Not applicable
- Endocrine-exocrine Functions and Prognosis After PancreatectomyRecruitingNCT07396662
- Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic CancerNot yet recruitingNCT07394205Early Phase 1
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic TestingRecruitingNCT07387263Not applicable
- A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic CancerNot yet recruitingNCT07383922Phase 3
- Delayed Gastric Emptying After Pancreatic SurgeryRecruitingNCT07382791
- Comparison of Transmesocolic Versus Retromesenteric Reconstruction in Cephalic Duodenopancreatectomy (FAST Trial)Not yet recruitingNCT07368218Not applicable
- MRinRT: Swansea University and SWWCC Collaboration Study.Not yet recruitingNCT07365124
- Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic TumorsRecruitingNCT07360119Not applicable
- Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaRecruitingNCT07359586
- Axelopran for Advanced Cancer in Patients Receiving OpioidsRecruitingNCT07354919Phase 2
- KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic CancerRecruitingNCT07353645Phase 1/2
- Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsRecruitingNCT07349537Phase 1
- Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye ConjugateEnrolling by invitationNCT07344220Phase 2
- Hepatobiliary and Pancreatic Tumor BiobankNot yet recruitingNCT07344116
- FAPi PET in Pancreatic Ductal AdenocarcinomaRecruitingNCT07342231
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic CancerNot yet recruitingNCT07325214Not applicable
- Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
- LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm StudyRecruitingNCT07312422Phase 1/2
- Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant TumorsRecruitingNCT07301814